News, Articles & Resources
Cancer Research and Cancer Support Articles
Some conditions cause your body to overproduce red blood cells or iron. A phlebotomy will remove some of these cells.
Triple-negative breast cancer lacks three common receptors found in many other breast cancers: estrogen, progesterone, and HER2 protein. Learn more.
Bone marrow biopsy and bone marrow aspiration are procedures to collect and examine bone marrow. Learn More.
HER2-positive breast cancer is a type in which the cancer cells make too much of a protein called human epidermal growth factor receptor 2. Learn more.
FCS clinicians share expertise at the FLASCO Fall Oncology Congress to advance cancer care and improve patient outcomes.
In this video John Sodeika discusses his journey to recovery after being diagnosed with advanced gastric cancer.
Florida Cancer Specialists & Research Institute leaders join executive oncology peers at the Association of Value-Based Cancer Care 2025 in New York City.
23 FCS abstracts to be presented at the European Society of Medical Oncology Congress 2025 including one oral presentation.
FCS Top News Updates
August 17, 2026
FCS Welcomes Arushi Thaper, MD to Orange County Team
August 10, 2026
FCS Welcomes Neel K. Gakhar, MD
August 4, 2026
FCS Expands Martin County Team with Elizabeth Blowers, MD, PhD
August 3, 2026
FCS Welcomes Nagapratap Ganta, MD and Aryanna Jordan, MD to Statewide Practice
Therapeutic PhlebotomySome conditions cause your body to overproduce red blood cells or iron. A phlebotomy will remove some of these cells.
Triple Negative Breast Cancer -Summary, Symptoms, TreatmentsTriple-negative breast cancer lacks three common receptors found in many other breast cancers: estrogen, progesterone, and HER2 protein. Learn more.
Bone Marrow BiopsyBone marrow biopsy and bone marrow aspiration are procedures to collect and examine bone marrow. Learn More.
HER2-Positive Breast Cancer – Summary, Symptoms, TreatmentsHER2-positive breast cancer is a type in which the cancer cells make too much of a protein called human epidermal growth factor receptor 2. Learn more.
FCS Clinicians Offer Insights on Optimizing Patient Outcomes at Statewide CongressFCS clinicians share expertise at the FLASCO Fall Oncology Congress to advance cancer care and improve patient outcomes.
The Path of a Patient Sample – VideoIn this video John Sodeika discusses his journey to recovery after being diagnosed with advanced gastric cancer.
FCS Leaders Convene With Executive Peers at Value-Based Cancer Care SummitFlorida Cancer Specialists & Research Institute leaders join executive oncology peers at the Association of Value-Based Cancer Care 2025 in New York City.
FCS Shaping the Future of Cancer Care at Global Congress23 FCS abstracts to be presented at the European Society of Medical Oncology Congress 2025 including one oral presentation.